Baird Financial Group, Inc. Bei Gene, Ltd. Transaction History

Baird Financial Group, Inc.

$50.2 Billion
Q3 2024

A detailed history of Baird Financial Group, Inc. transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 287,114 shares of BGNE stock, worth $51.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

287,114

Previous 262,110 9.54%

Holding current value

$51.4 Million

Previous $37.4 Million 72.37%

% of portfolio

0.13%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$143.93 - $224.51 $3.6 Million - $5.61 Million	25,004 Added 9.54%	287,114 $64.5 Million
Q2 2024 Aug 13, 2024	BUY	$129.52 - $174.32 $1.46 Million - $1.96 Million	11,243 Added 4.48%	262,110 $37.4 Million
Q1 2024 May 14, 2024	BUY	$141.8 - $181.47 $12.2 Million - $15.6 Million	85,934 Added 52.1%	250,867 $39.2 Million
Q4 2023 Feb 14, 2024	BUY	$158.67 - $201.58 $5.47 Million - $6.95 Million	34,481 Added 26.43%	164,933 $29.7 Million
Q3 2023 Nov 13, 2023	BUY	$179.87 - $225.13 $2.75 Million - $3.44 Million	15,264 Added 13.25%	130,452 $23.5 Million
Q2 2023 Aug 11, 2023	BUY	$178.3 - $266.78 $1.6 Million - $2.4 Million	8,982 Added 8.46%	115,188 $20.5 Million
Q1 2023 May 15, 2023	BUY	$215.53 - $274.5 $647,883 - $825,147	3,006 Added 2.91%	106,206 $22.9 Million
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $764,967 - $1.17 Million	5,804 Added 5.94%	103,576 $14 Million
Q2 2022 Aug 08, 2022	BUY	$121.11 - $216.05 $505,028 - $900,928	4,170 Added 4.46%	97,772 $15.8 Million
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $1.31 Million - $2.42 Million	8,967 Added 10.59%	93,602 $17.7 Million
Q4 2021 Feb 09, 2022	BUY	$248.56 - $389.34 $159,824 - $250,345	643 Added 0.77%	84,635 $22.9 Million
Q3 2021 Nov 12, 2021	BUY	$249.6 - $403.14 $1.03 Million - $1.66 Million	4,123 Added 5.16%	83,992 $30.5 Million
Q2 2021 Aug 11, 2021	BUY	$292.75 - $367.01 $1.89 Million - $2.37 Million	6,465 Added 8.81%	79,869 $27.4 Million
Q1 2021 May 13, 2021	SELL	$260.64 - $382.12 $2.24 Million - $3.28 Million	-8,589 Reduced 10.48%	73,404 $25.6 Million
Q4 2020 Feb 11, 2021	BUY	$221.31 - $316.61 $451,472 - $645,884	2,040 Added 2.55%	81,993 $21.2 Million
Q3 2020 Nov 12, 2020	BUY	$189.18 - $286.44 $441,924 - $669,123	2,336 Added 3.01%	79,953 $22.9 Million
Q2 2020 Aug 14, 2020	BUY	$123.9 - $195.41 $369,469 - $582,712	2,982 Added 4.0%	77,617 $15,000
Q1 2020 May 14, 2020	BUY	$121.84 - $173.19 $9.09 Million - $12.9 Million	74,635 New	74,635 $9.19 Million

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Account

Baird Financial Group, Inc. Bei Gene, Ltd. Transaction History